Table 2 Uptake of IPTp-SP by study arm
Intervention (n = 510) | Control (n = 508) | Difference | p-value | |
|---|---|---|---|---|
Nasarawa State, Nigeria | ||||
Mean doses of IPTp-SP received (SD) | 3.45 (1.53) | 2.14 (1.55) | − 1.31 | < 0.001 |
Doses of IPTp-SP received during ANC | n (%) | n (%) | ||
2+ | 467 (91.6) | 308 (60.6%) | 31.0 | < 0.001 |
3+ | 347 (68.0) | 183 (36.0) | 32.0 | 0.052 |
4+ | 268 (52.6) | 83 (16.3) | 36.3 | 0.004 |
5+ | 146 (29.6) | 43 (8.5) | 21.1 | 0.034 |
Intervention (n = 211) | Control (n = 208) | Difference | p-value | |
|---|---|---|---|---|
Kisumu County, Kenya | ||||
Mean doses of IPTp-SP received (SD) | 3.81 (2.35) | 2.72 (1.65) | 1.09 | < 0.001 |
Doses of IPTp-SP received during ANC | n (%) | n (%) | ||
2+ | 163 (77.3) | 150 (72.1) | 5.2 | 0.590 |
3+ | 156 (73.9) | 116 (55.8) | 18.1 | 0.100 |
4+ | 131 (62.1) | 77 (37.0) | 25.1 | 0.056 |
5+ | 97 (46.0) | 27 (13.0) | 33.0 | < 0.001 |